GE's healthcare unit on Tuesday reported that third-quarter revenues of $4.3 billion decreased 6% organically due to ongoing industry-wide supply chain shortages.
The supply chain hit to the conglomerate's healthcare division was the biggest of any business unit, GE executives told investors on Tuesday's earnings call, adding they expect disruptions to last through at least the first half of 2022.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,